| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/25/2008 | US7348147 Method and system for nucleic acid detection |
| 03/25/2008 | US7348146 Single nucleotide polymorphism analysis of highly polymorphic target sequences |
| 03/25/2008 | US7348145 Multiplex polymerase chain reaction assays using consensus primers to amplify conserved regions of the DNA; hybridizing products onto substrate; chemiluminescence |
| 03/25/2008 | US7348144 Methods and system for multi-drug treatment discovery |
| 03/25/2008 | US7348143 Method of visualizing non-targeted metabolomic data generated from fourier transform ion cyclotron resonance mass spectrometers |
| 03/25/2008 | US7348142 By identifying differential modulation in a combination of genes selected from two groups |
| 03/25/2008 | US7348141 For single nucleotide polymorphisms (SNPs) using fluorescently labelled oligonucleotide probes; solid phase synthesis |
| 03/25/2008 | US7348140 Clinical indications for genotyping polymorphic variants of G-protein coupled receptors |
| 03/25/2008 | US7348138 Diagnostic methods and kits for identifying individuals exposed to West Nile virus or other viruses including Flavivirus or Pestivirus |
| 03/25/2008 | US7348137 Determination of testosterone by mass spectrometry |
| 03/25/2008 | US7348136 Immunoglobulins specific to feline immunodeficiency virus envelope protein as a diagnostic indicator of RNA viral infection; immunodiagnostics; veterinary medicine |
| 03/25/2008 | US7348135 Assessing integrity of mitochondrial membrane via cyclic enzymatic reactions involving intra-mitochondrial compounds; identifying compounds which decrease membrane permeablity of mitochondria; screening microbiocides |
| 03/25/2008 | US7348134 Cell-free system for translation and formation of HTLV lymphadenopathy associated viral coat proteins; viricides; drug screening |
| 03/25/2008 | US7347995 comprising an agent that targets an interleukin-15 receptor and a second agent that inhibits a costimulatory signal transmitted between a T cell and an antigen-presenting cell; treating autoimmune diseases, AIDS, vascular injuries or organ, tissue or cell transplant recipients |
| 03/25/2008 | US7347973 determination chemical and biological constituents in bodily fluid; applying sample to test strips; storage results in computer |
| 03/25/2008 | US7347921 Apparatus and method for threading a biopolymer through a nanopore |
| 03/25/2008 | CA2348776C High fidelity thermostable ligase and uses thereof |
| 03/25/2008 | CA2243578C High affinity nucleic acid ligands of complement system proteins |
| 03/25/2008 | CA2222744C Thermostable dna polymerases |
| 03/25/2008 | CA2157202C Leuco dye coating compositions |
| 03/25/2008 | CA2115579C Ryegrass pollen allergen |
| 03/25/2008 | CA2073500C Compositions and methods for detecting and modulating rna activity and gene expression |
| 03/21/2008 | CA2560352A1 High-throughput automated cellular injection system and method |
| 03/20/2008 | WO2008034129A2 Treatment of cancer or obesity with conjugated linoleic acids |
| 03/20/2008 | WO2008034110A2 Use of taq polymerase mutant enzymes for dna amplification in the presence of pcr inhibitors |
| 03/20/2008 | WO2008033992A2 High throughput screening assay for histone modifying enzyme modulators |
| 03/20/2008 | WO2008033936A2 Removal of molecular assay interferences for nucleic acids employing buffered solutions of chaotropes |
| 03/20/2008 | WO2008033782A2 Methods and compositions for the diagnosis and treatment of lung cancer using pdgfra, kit or kdr gene as genetic marker |
| 03/20/2008 | WO2008033776A1 Probes and methods for detecting gleevec-resistant bcr-abl mutations |
| 03/20/2008 | WO2008033717A2 Method of processing active materials for use in secondary electrochemical cells |
| 03/20/2008 | WO2008033535A2 Amine-reactive biosensor |
| 03/20/2008 | WO2008033461A2 Methods for the identification, evaluation and treatment of patients having cc-chemokine receptor 2(ccr-2) mediated disorders |
| 03/20/2008 | WO2008033442A2 Methods and compositions for performing low background multiplex nucleic acid amplification reactions |
| 03/20/2008 | WO2008033408A2 Methods for identifying compounds that modulate cell signaling and methods employing such compounds |
| 03/20/2008 | WO2008033374A2 Ocl-2a3 compositions and uses thereof |
| 03/20/2008 | WO2008033368A2 Boroproline compound and cytokine combination therapy |
| 03/20/2008 | WO2008033326A2 Method for determining treatment of individuals with fragile site |
| 03/20/2008 | WO2008033239A2 Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof |
| 03/20/2008 | WO2008033164A1 Magnetic particle tagged reagents and techniques |
| 03/20/2008 | WO2008033016A1 Control system for uv lamps, and check system for determining the viability of microorganisms |
| 03/20/2008 | WO2008032921A1 Htsnps for determining a genotype of cytochrome p450 1a2, 2a6 and 2d6, pxr and udp-glucuronosyltransferase 1a gene and multiplex genotyping methods using thereof |
| 03/20/2008 | WO2008032905A1 Genes involved in differentiation of human stem cell lines and the microarray kit containing these genes |
| 03/20/2008 | WO2008032876A1 Preventive or remedy for er-negative and her2-negative breast cancer and method of screening the same |
| 03/20/2008 | WO2008032874A1 Method for screening for agent capable of controlling in vivo hypoxia-responsive system |
| 03/20/2008 | WO2008032871A2 Electron transfer mediator modified enzyme electrode and biofuel cell comprising the same |
| 03/20/2008 | WO2008032868A1 Tumor marker for renal cancer and method for determination of occurrence of renal cancer |
| 03/20/2008 | WO2008032761A1 Detection marker for malignant tumor in urinary system, and detection kit and method for detection of malignant tumor in urinary system using the marker |
| 03/20/2008 | WO2008032760A1 Detection marker for cervical cancer, and detection kit and cervical cancer determination method using the marker |
| 03/20/2008 | WO2008032599A1 Semiconductor nanoparticle aggregate, process for producing the semiconductor nanoparticle aggregate, and biological substance labeling agent using the semiconductor nanoparticle aggregate |
| 03/20/2008 | WO2008032535A1 Fluorescent semiconductor microparticle, method for production of the microparticle, fluorescent labeling agent for biological substance using the microparticle, and bioimaging method using the microparticle |
| 03/20/2008 | WO2008032534A1 Fluorescent semiconductor microparticle assembly, fluorescent labeling agent assembly for biological substance, and bioimaging method and biological substance analysis method using the assemblies |
| 03/20/2008 | WO2008032218A2 Diagnosis of hereditary spastic paraplegias (hsp) by detection of a mutation in the kiaa1840 gene or protein |
| 03/20/2008 | WO2008032210A2 Methods of using sip-10 to assess hcv clearance and/or response to interferon therapy |
| 03/20/2008 | WO2008032153A2 Calreticulin for its use as a medication for the treatment of cancer in a mammal |
| 03/20/2008 | WO2008032066A1 Methods and devices for detecting structural changes in a molecule measuring electrochemical impedance |
| 03/20/2008 | WO2008032056A2 Dopamine receptor interacting proteins as markers for disease |
| 03/20/2008 | WO2008031857A1 A method for specific detection of salmonella spp |
| 03/20/2008 | WO2008031854A2 Nucleic acids for expressing a polynucleotide of interest in mammalian cancer cells |
| 03/20/2008 | WO2008031846A1 Genomic marker for meat tenderness |
| 03/20/2008 | WO2008031839A2 Gene expression signature for the prognosis, diagnosis, and therapy of prostate cancer and uses thereof |
| 03/20/2008 | WO2008031230A1 Methods of determining susceptibility of cells to reovirus infection and methods for treating cellular proliferative disorders with reovirus |
| 03/20/2008 | WO2008031228A1 Automated fish analysis, circulating microfluidic chip, and method for immobilizing cells to a microfluidic chip |
| 03/20/2008 | WO2008031226A1 Mammalian oocyte development competency granulosa markers and uses thereof |
| 03/20/2008 | WO2008016909A3 Nucleotide analogs |
| 03/20/2008 | WO2008008500A9 Methods for making cancer prognoses based on the subcellular localization of biomarkers |
| 03/20/2008 | WO2008003656A3 Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics |
| 03/20/2008 | WO2007149484A9 Inhibitors of usp1 deubiquitinating enzyme complex |
| 03/20/2008 | WO2007149350A3 Methods and compositions for obtaining amplifiable nucleic acids from tissues, cells, or viruses exposed to transport media |
| 03/20/2008 | WO2007147079A3 Rare cell analysis using sample splitting and dna tags |
| 03/20/2008 | WO2007134210A3 Methods and compositions for the diagnosis and treatment of cancer |
| 03/20/2008 | WO2007130431A3 FUNCTION OF ESTROGEN RELATED RECEPTOR GAMMA (ERRγ) IN INCREASING MITOCHONDRIAL BIOGENESIS |
| 03/20/2008 | WO2007130399A3 Method of determining genetic predisposition for deficiency in health functions using snp analysis |
| 03/20/2008 | WO2007124085A3 Device for quantification of radioisotope concentrations in a micro-fluidic platform |
| 03/20/2008 | WO2007118144A3 High resolution chromosomal mapping |
| 03/20/2008 | WO2007104318A3 Oligonucleotides comprising signalling pairs and hydrophobic nucleotides, stemless beacons, for detection of nucleic acids, methylation status and mutants of nucleic acids |
| 03/20/2008 | WO2007092861A3 Inhibitors specific of presenilin-1 and their uses |
| 03/20/2008 | WO2007053502A3 Mutations and polymorphisms of hdac5 |
| 03/20/2008 | WO2007039319A8 Dna microarray for rapid identification of candida albicans in blood cultures |
| 03/20/2008 | WO2005040400A3 Methods and systems for inferring traits to manage non-beef livestock |
| 03/20/2008 | WO2004111075A3 Alternative reading frame polypeptides for treatment |
| 03/20/2008 | US20080072352 Isolated polynucleotides and polypeptides relating to loci underlying resistance to soybean cyst nematode and soybean sudden death syndrome and methods employing same |
| 03/20/2008 | US20080072340 Nucleotide sequences and corresponding polypeptides conferring modulated plant characteristics |
| 03/20/2008 | US20080071076 Non-invasive detection of fetal genetic traits |
| 03/20/2008 | US20080071069 For delivering DNA/RNA into cells |
| 03/20/2008 | US20080071066 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 03/20/2008 | US20080071065 Fibroblast Growth Factor-Like Polypeptides |
| 03/20/2008 | US20080070995 Methods and Compositions Relating to Alzheimer's Disease |
| 03/20/2008 | US20080070929 Thiazoline and oxazoline derivatives and their methods of use |
| 03/20/2008 | US20080070838 Growth Factor Treatment for Asthma |
| 03/20/2008 | US20080070836 Zinc transporter LIV1 can be used as an epithelial-mesenchymal transition (EMT) regulatory agent; further, because EMT is involved in cancer progression, LIV1 antisense nucleotides and the like may be used as pharmaceuticals for treating cancer |
| 03/20/2008 | US20080070804 Synthetic substrates and inhibitors with enhanced specificity |
| 03/20/2008 | US20080070800 Elucidation of Gene Function |
| 03/20/2008 | US20080070799 Binding molecules capable of neutralizing rabies virus and uses thereof |
| 03/20/2008 | US20080070798 Nucleotide sequencing via repetitive single molecule hybridization |
| 03/20/2008 | US20080070797 Nucleic acid arrays for detecting gene expression associated with human osteoarthritis and human proteases |
| 03/20/2008 | US20080070796 Complexity Management of Genomic DNA |
| 03/20/2008 | US20080070793 Markers for the diagnosis of aml, b-all and t-all |
| 03/20/2008 | US20080070792 Use of highly parallel snp genotyping for fetal diagnosis |
| 03/20/2008 | US20080070293 Enzyme-based monitoring device for thermal processing of objects |
| 03/20/2008 | US20080070283 Microarray comprising immobilized oligonucleotides for use in propagation/replication of preferential nucleotide sequences |